A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCC.
- Resource Type
- Article
- Authors
- Kim, Miso; McDermott, Raymond S.; Williamson, Stephen K.; Cho, Byoung Chul; Dowlati, Afshin; Lakhani, Nehal J.; Malhotra, Jyoti; Kaczmar, John M.; Papadopoulos, Kyriakos P.; Safran, Howard; Aljumaily, Raid; Mani, Jayakumar; Fang, Fang; Chen, Shuquan; Salvati, Mark; Lowy, Israel; Fury, Matthew G.; Lewis, Karl
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p434-434, 140p
- Subject
- Language
- ISSN
- 0732183X